BACTERIAL QUALITY AND CYTOTOXICITY SCREENING OF FRESH VEGETABLES IRRIGATED WITH POLLUTED WATERS

The mutagenic effects of raw vegetables irrigated with polluted water and their bacterial quality were studied. Two vegetables, lettuce (Lactuca sativa) and fluted pumpkin (Telfaria occidentalis) were planted in sterile soil and irrigated with sewage-polluted stream, rain, tap and well waters, and harvested. The presence of pathogenic bacteria on the vegetable leaf surfaces was determined. The Allium cepa assay was then used to evaluate the genetic and acute effects of the vegetable leaf extracts. The heavy metal concentrations of the vegetables were determined using atomic absorption spectrophotometry. Pathogenic bacteria isolated were Escherichia coli, Staphylococcus aureus, Salmonella paratyphii, Shigella dysenteriae, Klebsiella pneumoniae, Aeromonas hydrophila and Enterobacter aerogenes. In A. cepa assay, none of the treatments induced chromosome aberration at the tested concentrations, but retardation of growth and suppression of mitotic activity occurred. The concentrations of heavy metals in the vegetables were lead (0.261-0.531mg/kg), zinc (0.142-1.618mg/kg), cadmium (0.00-0.13mg/kg), copper (0.021-0.057mg/kg), iron (0.711-1.122mg/kg) and chromium (0.00-0.14mg/kg). This study shows that irrigation waters could have effects on the quality of edible vegetables.Â

Conventional Use of Honey as Antibacterial Agent

Background: Honey has since been found to possess antibacterial property and is therefore employed for wound therapy. The current problems with conventional antibacterial agents, led to the choice of honey as well as other natural products by the populace, in the treatment of bacterial infections. The present study evaluates the antibacterial spectrum and efficacy of honey and compared same with tetracycline and ciprofloxacin. Methods: Different concentrations (12.5, 25.0, 50.0 and 100.0 %) of honey were studied in - vitro using Staphylococcus aureus , Staphylococcus albus , Streptococcus faecalis , Klebsiella sp., Proteus mirabilis , Pseudomonas aeruginosa , and Escherichia coli . Results: The data obtained showed a dose dependent inhibitory action of honey, except with Streptococcus faecalis where there was no growth inhibition. The minimum inhibitory concentration (MIC) of honey presented Staphylococcus albus as the most susceptible organism and Escherichia coli, the least. While ciprofloxacin (2.0 mg/ml) exerted a greater potency than honey, tetracycline was found to be less potent than 100% concentration of honey, except with Escherichia coli. Conclusion: The antibacterial action of honey was observed with 50% as well as the neat concentration. However, ciprofloxacin exhibited a greater potency and efficacy as well as a broader spectrum than honey, which shows that where a broad spectrum antibacterial is required, the conventional drugs, especially the newer ones are preferred to honey.Introduction : Depuis bien longtemps, on disait que le miel poss\ue8de des vertus antibact\ue9riens et donc on l'utilisait pour la th\ue9rapie des blessures. Des probl\ue8mes actuels li\ue9s aux agents conventionnels antibact\ue9rien, a provoqu\ue9 le choix du miel de m\ueame que d'autres produits naturels par le peuple, dans la prise en charge des infections bact\ue9riennes. Cette \ue9tude fait une \ue9valuation du spectre antibact\ue9rien et l'efficacit\ue9 du miel par rapport au t\ue9tracycline et ciproflocine. M\ue9thode : Des concentrations diverses (12,5 ; 25,0 ; 50,0 et 100,0%) du miel ont \ue9t\ue9 \ue9tudi\ue9s in-vitro \ue0 travers l'utilisation du staphylococcus aureus, staphylococcus albus, streptococcus faecalis, klebsiella sp., proteus mirabilis, pseudomonas aeruginose, et escherichia coli. R\ue9sultats : Les donn\ue9es obtenues avaient montr\ue9 une action inhibiteur d'une dose d\ue9pendante du miel \ue0 l'exception du S. faecalis l\ue0 o\uf9 il n'y avait aucune inhibition de croissance. La concentration inhibiteur minimum (CIM) du miel a pr\ue9sent\ue9 S. albus comme un organisme le plus susceptible et E. coli le moins, Tandis que ciprofloxacine (2.0mg/ml) a donn\ue9 une plus grande efficacit\ue9 que du miel, t\ue9tracycline \ue9tait not\ue9e d'avoir le moindre efficacit\ue9 que 100% concentration du miel \ue0 l'exception du E. Coli. Conclusion : L'action antibact\ue9rienne du miel \ue9tait not\ue9e avec 50% de m\ueame que la concentration ing\ue9nieuse. Toutefois, la ciprofloxacine a donn\ue9 une plus grande efficacit\ue9 de m\ueame que un large spectre plus que du miel qui montre que l\ue0 o\uf9 un tr\ue8s grand spectre antibact\ue9rien est exig\ue9, des drogues conventionnelles, des nouvelles drogues en particulier sont pr\ue9f\ue9r\ue9s au miel

Indoor environmental conditions of selected shopping malls in Nigeria: A comparative study of microclimatic conditions, noise levels, and microbial burdens

oai:repository.uel.ac.uk:8x3x4The activities of people and equipment used within shopping malls are major factors that contribute to air pollution and increased sound levels, thereby affecting indoor environmental quality and the well-being of mall operators. This study assessed indoor environmental quality through microbial characterization and measurement of environmental conditions present in selected shopping malls. Investigations were conducted at three shopping malls in Ibadan selected through convenience sampling technique. Environmental parameters such as noise level, relative humidity, temperature, PM₂.₅ levels, total volatile organic compound (TVOC) levels, microbial characterization, and quantity were determined. Microclimatic parameters (temperature and relative humidity) were measured using a 4-in-1 Precision Gold N09AQ multi-tester. Culturable airborne microbes were collected using the settle plate technique. PM₂.₅ and TVOC levels were measured using a Thermo Scientific MIE pDR-1500 PM monitor and sf200-TVOC meter respectively. Two bacteria species and five fungi species were isolated across the malls. The noise levels ranged from 61.27 to 81.20 dB. The mean temperatures (highest mean of 33.44 ± 1.42 °C), PM₂.₅ (highest mean of 114.06 ± 25.64 μg/m³), and TVOC (highest mean of 55.21 ± 8.28 ppm) concentrations were higher than the permissible limits stipulated by the WHO guidelines and NESREA standard limits across all the selected malls. A positive correlation was found to exist between particulate matter and TVOC (r = 0.174, p = 0.004). The total bacteria count was generally high with the highest mean of 1965.33 ± 368.56 CFU/m³, while the total fungi count was generally low with the highest mean of 579.82 ± 51.55 CFU/m³. Bacillus spp. and Candida spp. were found to the consistent from all sample points across the three malls. The bacteria isolated are Gram-positive bacteria associated with human skin which suggests a high rate of indoor pollution from humans. In conclusion, this research has demonstrated the necessity to monitor noise levels and indoor air quality in malls. Also, there is need for government policies to improve indoor air quality which must be enforced and regulated, especially within shopping malls

Planktic foraminifera form their shells via metastable carbonate phases

The calcium carbonate shells of planktic foraminifera provide our most valuable geochemical archive of ocean surface conditions and climate spanning the last 100 million years, and play an important role in the ocean carbon cycle. These shells are preserved in marine sediments as calcite, the stable polymorph of calcium carbonate. Here, we show that shells of living planktic foraminifers Orbulina universa and Neogloboquadrina dutertrei originally form from the unstable calcium carbonate polymorph vaterite, implying a non-classical crystallisation pathway involving metastable phases that transform ultimately to calcite. The current understanding of how planktic foraminifer shells record climate, and how they will fare in a future high-CO 2 world is underpinned by analogy to the precipitation and dissolution of inorganic calcite. Our findings require a re-evaluation of this paradigm to consider the formation and transformation of metastable phases, which could exert an influence on the geochemistry and solubility of the biomineral calcite

Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus – A MASTERMIND precision medicine approach (UKPDS 87)

This is the author accepted manuscript. The final version is available from Elsevier via the DOI in this record Aims: Predicting likely durability of glucose-lowering therapies for people with type 2 diabetes (T2D) could help inform individualised therapeutic choices. Methods: We used data from UKPDS patients with newly-diagnosed T2D randomised to first-line glucose-lowering monotherapy with chlorpropamide–glibenclamide–basal insulin or metformin. In 2339 participants who achieved one-year HbA1c values <7.5% (<59 mmol/mol)–we assessed relationships between one-year characteristics and time to monotherapy-failure (HbA1c ≥ 7.5% or requiring second-line therapy). Model validation was performed using bootstrap sampling. Results: Follow-up was median (IQR) 11.0 (8.0–14.0) years. Monotherapy-failure occurred in 72%–82%–75% and 79% for those randomised to chlorpropamide–glibenclamide–basal insulin or metformin respectively–after median 4.5 (3.0–6.6)–3.7 (2.6–5.6)–4.2 (2.7–6.5) and 3.8 (2.6– 5.2) years. Time-to-monotherapy-failure was predicted primarily by HbA1c and BMI values–with other risk factors varying by type of monotherapy–with predictions to within ±2.5 years for 55%–60%–56% and 57% of the chlorpropamide–glibenclamide–basal insulin and metformin monotherapy cohorts respectively. Conclusions: Post one-year glycaemic durability can be predicted robustly in individuals with newly-diagnosed T2D who achieve HbA1c values < 7.5% one year after commencing traditional monotherapies. Such information could be used to help guide glycaemic management for individual patients.Medical Research Council (MRC

Protocol for implementation of family health history collection and decision support into primary care using a computerized family health history system

<p>Abstract</p> <p>Background</p> <p>The CDC's Family History Public Health Initiative encourages adoption and increase awareness of family health history. To meet these goals and develop a personalized medicine implementation science research agenda, the Genomedical Connection is using an implementation research (T3 research) framework to develop and integrate a self-administered computerized family history system with built-in decision support into 2 primary care clinics in North Carolina.</p> <p>Methods/Design</p> <p>The family health history system collects a three generation family history on 48 conditions and provides decision support (pedigree and tabular family history, provider recommendation report and patient summary report) for 4 pilot conditions: breast cancer, ovarian cancer, colon cancer, and thrombosis. All adult English-speaking, non-adopted, patients scheduled for well-visits are invited to complete the family health system prior to their appointment. Decision support documents are entered into the medical record and available to provider's prior to the appointment. In order to optimize integration, components were piloted by stakeholders prior to and during implementation. Primary outcomes are change in appropriate testing for hereditary thrombophilia and screening for breast cancer, colon cancer, and ovarian cancer one year after study enrollment. Secondary outcomes include implementation measures related to the benefits and burdens of the family health system and its impact on clinic workflow, patients' risk perception, and intention to change health related behaviors. Outcomes are assessed through chart review, patient surveys at baseline and follow-up, and provider surveys. Clinical validity of the decision support is calculated by comparing its recommendations to those made by a genetic counselor reviewing the same pedigree; and clinical utility is demonstrated through reclassification rates and changes in appropriate screening (the primary outcome).</p> <p>Discussion</p> <p>This study integrates a computerized family health history system within the context of a routine well-visit appointment to overcome many of the existing barriers to collection and use of family history information by primary care providers. Results of the implementation process, its acceptability to patients and providers, modifications necessary to optimize the system, and impact on clinical care can serve to guide future implementation projects for both family history and other tools of personalized medicine, such as health risk assessments.</p

11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

Glucocorticoids prescribed to limit inflammation, have significant adverse effects. As 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) regenerates active glucocorticoid, we investigated whether 11β-HSD1 inhibition with AZD4017 could mitigate adverse glucocorticoid effects without compromising their anti-inflammatory actions. We conducted a proof-of-concept, randomized, double-blind, placebo-controlled study at Research Unit, Churchill Hospital, Oxford, UK (NCT03111810). 32 healthy male volunteers were randomized to AZD4017 or placebo, alongside prednisolone treatment. Although the primary endpoint of the study (change in glucose disposal during a two-step hyperinsulinemic, normoglycemic clamp) wasn’t met, hepatic insulin sensitivity worsened in the placebo-treated but not in the AZD4017-treated group. Protective effects of AZD4017 on markers of lipid metabolism and bone turnover were observed. Night-time blood pressure was higher in the placebo-treated but not in the AZD4017-treated group. Urinary (5aTHF+THF)/THE ratio was lower in the AZD4017-treated but remained the same in the placebo-treated group. Most anti-inflammatory actions of prednisolone persisted with AZD4017 co-treatment. Four adverse events were reported with AZD4017 and no serious adverse events. Here we show that co-administration of AZD4017 with prednisolone in men is a potential strategy to limit adverse glucocorticoid effects

Challenges and opportunities in the design and construction of a GIS-based emission inventory infrastructure for the Niger Delta region of Nigeria

© 2017, Springer-Verlag Berlin Heidelberg. Environmental monitoring in middle- and low-income countries is hampered by many factors which include enactment and enforcement of legislations; deficiencies in environmental data reporting and documentation; inconsistent, incomplete and unverifiable data; a lack of access to data; and technical expertise. This paper describes the processes undertaken and the major challenges encountered in the construction of the first Niger Delta Emission Inventory (NDEI) for criteria air pollutants and CO2 released from the anthropogenic activities in the region. This study focused on using publicly available government and research data. The NDEI has been designed to provide a Geographic Information System-based component of an air quality and carbon management framework. The NDEI infrastructure was designed and constructed at 1-, 10- and 20-km grid resolutions for point, line and area sources using industry standard processes and emission factors derived from activities similar to those in the Niger Delta. Due to inadequate, incomplete, potentially inaccurate and unavailable data, the infrastructure was populated with data based on a series of best possible assumptions for key emission sources. This produces outputs with variable levels of certainty, which also highlights the critical challenges in the estimation of emissions from a developing country. However, the infrastructure is functional and has the ability to produce spatially resolved emission estimates

11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

Glucocorticoids prescribed to limit inflammation, have significant adverse effects. As 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) regenerates active glucocorticoid, we investigated whether 11β-HSD1 inhibition with AZD4017 could mitigate adverse glucocorticoid effects without compromising their anti-inflammatory actions. We conducted a proof-of-concept, randomized, double-blind, placebo-controlled study at Research Unit, Churchill Hospital, Oxford, UK (NCT03111810). 32 healthy male volunteers were randomized to AZD4017 or placebo, alongside prednisolone treatment. Although the primary endpoint of the study (change in glucose disposal during a two-step hyperinsulinemic, normoglycemic clamp) wasn’t met, hepatic insulin sensitivity worsened in the placebo-treated but not in the AZD4017-treated group. Protective effects of AZD4017 on markers of lipid metabolism and bone turnover were observed. Night-time blood pressure was higher in the placebo-treated but not in the AZD4017-treated group. Urinary (5aTHF+THF)/THE ratio was lower in the AZD4017-treated but remained the same in the placebo-treated group. Most anti-inflammatory actions of prednisolone persisted with AZD4017 co-treatment. Four adverse events were reported with AZD4017 and no serious adverse events. Here we show that co-administration of AZD4017 with prednisolone in men is a potential strategy to limit adverse glucocorticoid effects